Codexis (CDXS) Tax Provisions (2010 - 2026)

Codexis (CDXS) recorded quarterly Tax Provisions of $36000.0 in Q1 2026, up 100.0% quarter-over-quarter from $18000.0 in Q4 2025, and up 227.27% on a YoY basis from $11000.0 in Q1 2025.

Codexis (CDXS) Tax Provisions (2010 - 2026) Analysis & Trends

Codexis' Tax Provisions history runs 17 years deep, the most recent figure standing at $36000.0 for Q1 2026.

  • In Q1 2026, Tax Provisions rose 227.27% year-over-year to $36000.0; the TTM figure through Mar 2026 stood at $72000.0 (up 111.76% YoY), while the FY2025 annual figure was $47000.0, up 38.24% from the prior year.
  • Tax Provisions was $36000.0 for Q1 2026 at Codexis, up from $18000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $151000.0 in Q4 2022 to a low of $3000.0 in Q4 2024.
  • Historically, Tax Provisions has averaged $27117.6 across 5 years, with a median of $10000.0 in 2024.
  • Biggest YoY gain for Tax Provisions was 1250.0% in 2022; the steepest drop was 92.73% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $151000.0 in 2022, then slumped by 76.82% to $35000.0 in 2023, then tumbled by 91.43% to $3000.0 in 2024, then jumped by 500.0% to $18000.0 in 2025, then soared by 100.0% to $36000.0 in 2026.
  • The last three Tax Provisions figures came in at $36000.0 (Q1 2026), $18000.0 (Q4 2025), and $8000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -11.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -859,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 216,000.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 221.50 Mn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn 36,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 36,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 10,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 3,000.00
Sep 30, 2024 10,000.00
Jun 30, 2024 10,000.00
Mar 31, 2024 10,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 9,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 16,000.00
Dec 31, 2022 151,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 108,000.00
Mar 31, 2022 9,000.00
Dec 31, 2021 68,000.00
Sep 30, 2021 110,000.00
Jun 30, 2021 8,000.00